RegentAtlantic Capital’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-4,567
Closed -$75.8K 794
2014
Q4
$75.8K Sell
4,567
-8,251
-64% -$174K 0.01% 503
2014
Q3
$417K Sell
12,818
-252
-2% -$8.56K 0.04% 268
2014
Q2
$457K Sell
13,070
-743
-5% -$24.4K 0.04% 260
2014
Q1
$438K Sell
13,813
-1,467
-10% -$40.8K 0.04% 258
2013
Q4
$387K Buy
15,280
+1
+0% +$24 0.04% 266
2013
Q3
$327K Sell
15,279
-231
-1% -$4.74K 0.04% 275
2013
Q2
$300K Buy
+15,510
New +$339K 0.04% 275

Other funds holding PTEN

RegentAtlantic Capital's PTEN Position: Q1 2015 in Review

RegentAtlantic Capital sold out of Patterson-UTI (PTEN) in Q1 2015, closing a stake of 4,567 shares — an estimated $75.8K sold.

RegentAtlantic Capital first reported a position in PTEN in Q2 2013 and held it in 7 quarters. The position peaked at $457K in Q2 2014. 258 funds tracked by Wall St. Rank hold PTEN as of Q1 2015.

  • RegentAtlantic Capital reported no remaining Patterson-UTI position as of Q1 2015 after selling out during the quarter.
  • RegentAtlantic Capital sold 4,567 Patterson-UTI shares in Q1 2015, an estimated $75.8K.
  • RegentAtlantic Capital first reported a position in Patterson-UTI in Q2 2013 and held it in 7 quarters.
  • RegentAtlantic Capital's Patterson-UTI position peaked at $457K in Q2 2014.
  • 258 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2015.

Based on RegentAtlantic Capital's 13F filing for Q1 2015, filed 27 Apr 2015.